NATERA INC

NASDAQ: NTRA (Natera, Inc.)

Last update: 2 days ago, 8:28AM

414.30

-21.70 (-4.98%)

Previous Close 436.00
Volume 2,431,778
Price / Earnings (Forward) 5.05
Price / Sales 22.56
Price / Book 34.38
52 Weeks Range
181.00 (-56%) — 437.41 (5%)
Profit Margin -10.36%
Operating Margin (TTM) -15.78%
Diluted EPS (TTM) -1.47
Quarterly Revenue Growth (YOY) 36.50%
Total Debt/Equity (MRQ) 15.78%
Current Ratio (MRQ) 3.87
Operating Cash Flow (TTM) 153.12 M
Levered Free Cash Flow (TTM) 120.93 M
Return on Assets (TTM) -8.87%
Return on Equity (TTM) -18.66%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Mixed Bullish
Diagnostics & Research (Global) Mixed Bullish
Stock Natera, Inc. Mixed Bullish

AIStockmoo Score

-0.2
Analyst Consensus 0.0
Insider Activity 0.0
Price Volatility -3.0
Technical Moving Averages 1.5
Technical Oscillators 2.0
Relative Valuation NA
Financial Health 2.0
Macro Environment -2.8
AI Insight NA
AI Technical NA
Weighted Average -0.20

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
NTRA - - - 34.38
MEDP - - - 32.38
IDXX - - - 28.28
ILMN - - - 15.43
GH - - - -
BLLN - - - 10.00

Select this tab to load the latest available analysis.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Sector Healthcare
Industry Diagnostics & Research
Investment Style Mid Growth
% Held by Insiders 3.24%
% Held by Institutions 96.37%

Ownership

Name Date Shares Held
Castle Hook Partners Lp 30 Jun 2026 2,596,276
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
BROPHY MICHAEL BURKES - 419.05 -1,979 -829,306
CHAPMAN STEVEN LEONARD - 419.01 -5,694 -2,385,857
FESKO JOHN - 418.09 -1,679 -701,980
MOSHKEVICH SOLOMON - 418.10 -2,172 -908,104
RABINOWITZ DANIEL - 417.93 -1,852 -774,003
RABINOWITZ MATTHEW - 410.82 -1,718 -705,789
SHEENA JONATHAN - 413.74 -3,628 -1,501,062
Aggregate Net Quantity -18,722
Aggregate Net Value ($) -7,806,101
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 416.95
Name Holder Date Type Quantity Price Value ($)
CHAPMAN STEVEN LEONARD Officer 28 Oct 2026 Automatic sell (-) 3,430 424.42 1,455,761
BROPHY MICHAEL BURKES Officer 28 Oct 2026 Automatic sell (-) 1,198 424.42 508,455
RABINOWITZ DANIEL Officer 28 Oct 2026 Automatic sell (-) 968 424.42 410,839
MOSHKEVICH SOLOMON Officer 28 Oct 2026 Automatic sell (-) 1,162 424.42 493,176
FESKO JOHN Officer 28 Oct 2026 Automatic sell (-) 898 424.42 381,129
SHEENA JONATHAN Director 28 Oct 2026 Automatic sell (-) 187 424.42 79,367
CHAPMAN STEVEN LEONARD Officer 27 Oct 2026 Automatic sell (-) 2,264 410.82 930,096
BROPHY MICHAEL BURKES Officer 27 Oct 2026 Automatic sell (-) 781 410.82 320,850
RABINOWITZ DANIEL Officer 27 Oct 2026 Automatic sell (-) 884 410.82 363,165
RABINOWITZ MATTHEW Officer 27 Oct 2026 Automatic sell (-) 1,718 410.82 705,789
MOSHKEVICH SOLOMON Officer 27 Oct 2026 Automatic sell (-) 1,010 410.82 414,928
FESKO JOHN Officer 27 Oct 2026 Automatic sell (-) 781 410.82 320,850
SHEENA JONATHAN Director 27 Oct 2026 Automatic sell (-) 291 410.82 119,549
SHEENA JONATHAN Director 21 Oct 2026 Automatic sell (-) 3,150 413.38 1,302,147
Show more

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria